Absorption and distribution kinetics of the major Parietaria judaica allergen (Par j 1) administered by noninjectable routes in healthy human beings

Journal of Allergy and Clinical Immunology

Volumn 100, Issue 1, 1997, Pages 122-129

  Bagnasco, Marcello ^a   Mariani, Giuliano ^b   Passalacqua, Giovanni ^a   Motta, Cinzia ^b   Bartolomei, Mirco ^b   Falagiani, Paolo ^c   Mistrello, Giovanni ^c   Canonica, Giorgio Walter ^a,b  

^a Allergy and Clinical Immunology Service   (Italy)

^b UNIVERSITY OF GENOA   (Italy)

^c Lofarma SpA   (Italy)

Author keywords

Iodine 123; Local nasal immunotherapy; Oral immunotherapy; Par j 1; Radiolabeling; Sublingual immunotherapy

Indexed keywords

ADULT; ALLERGY; ANTIGEN PURIFICATION; ANTIGEN RECOGNITION; ARTICLE; FEMALE; HUMAN; IMMUNOTHERAPY; MALE; NORMAL HUMAN; PRIORITY JOURNAL; TREATMENT OUTCOME;

EID: 0030855386     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0091-6749(97)70203-3     Document Type: Article

References (31)

1. Committee on the Safety of Medicines. CSM update. Desensitizing vaccines. Br Med J 1986;293:948.
2. Greenberg MA, Kaufman CR, Gonzales GE, Rosenblatt CD, Smith LJ, Summers RJ. Late and immediate systemic-allergic reactions to inhalant allergen immunotherapy. J Allergy Clin Immunol 1986;77:865-70.
3. Lockey RF, Benedict LM, Turkeltaub PC, Bukantz SC. Fatalities from immunotherapy and skin testing. J Allergy Clin Immunol 1987;79:660-77.
4. Mailing HJ, Weeke B, editors. EAACI Immunotherapy position paper. Allergy 1993;48(suppl):1-81.
5. Moller C, Dreborg S, Lanner A, Bj̈rksten B. Oral immunotherapy of children with rhinoconjunctivitis due to birch pollen allergy. Allergy 1986;41:271-9.
6. Taudorf E, Laursen CL, Lanner A, Bj̈rksten B, Dreborg S, Søborg M, et al. Oral immunotherapy in birch pollen hay fever. J Allergy Clin Immunol 1987;80:153-61.
7. Leng X, Fu YX, Ye ST, Duan SQ. A double blind trial of oral immunotherapy for Artemisia pollen asthma with evaluation of bronchial response to pollen allergen and serum specific IgE antibody. Ann Allergy 1990;64:27-31.
8. Giovane A, Bardare M, Passalacqua G, Ruffoni S, Scordamaglia A, Ghezzi E, et al. A three year double blind placebo-controlled study with specific oral immunotherapy to Dermatophagoides: evidence of safety and efficacy in pediatric patients. Clin Exp Allergy 1994;24:53-9.
9. Tari MG, Mancino M, Madonna F, Buzzoni L, Parmiani S. Immunologic evaluation of 24-month course of sublingual immunotherapy. Allergol Immunopathol 1994;22:209-16.
10. Tari MG, Mancino M, Monti G. Efficacy of sublingual immunotherapy in patients with rhinitis and asthma due to house dust mite. A double blind study. Allergol Immunopathol 1990;18:277-84.
11. Sabbah A, Hassoun S, Le Sellin J, Andre C, Sicard H. A double blind placebo controlled trial by the sublingual route of immunotherapy with a standardized grass pollen extract. Allergy 1994;49:309-13.
12. Troise C, Voltolini S, Canessa A, Pecora S, Negrini AC. Sublingual immunotherapy in Parietaria pollen induced rhinitis: a double blind study. J Invest Allergol Clin Immunol 1995;5:25-30.
13. Georgitis JW, Nickelsen JA, Wypych JI, Barde SH, Clayton WF, Reisman RE. Local intranasal immunotherapy with high-dose polymerized ragweed extract. Int Arch Allergy Appl Immunol 1986;76:170-3.
14. Andri L, Senna GE, Betteli C, Givanni S, Andri G, Falagiani P. Local nasal immunotherapy for Dermatophagoides-induced rhinitis: efficacy of a powder extract. J Allergy Clin Immunol 1993;91:587-96.
15. Andri L, Senna GE, Betteli C, Givanni S, Andri G, Falagiani P, et al. Local nasal immunotherapy in allergic rhinitis to Parietaria. Allergy 1992;47:318-23.
16. D'Amato G, Lobefalo G, Liccardi G, Cazzola M. A double blind placebo controlled trial of local nasal immunotherapy in allergic rhinitis to Parietaria pollen. Clin Exp Allergy 1995;25:141-8.
17. Passalacqua G, Albano M, Ruffoni S, Pronzato C, Riccio A, DiBerardino L, et al. Local nasal immunotherapy to Parietaria: evidence of reduction of allergic inflammation. Am J Respir Crit Care Med 1995;152:461-6.
18. Andri L, Senna GE, Andri G, Dama A, Givanni S, Betteli C, et al. Local nasal immunotherapy for birch allergic rhinitis with extract in powder form. Clin Exp Allergy 1995;25:1092-9.
19. Rak S, Hakanson L, Venge P. Immunotherapy abrogates the generation of eosinophil and neutrophil chemotactic activity. J Allergy Clin Immunol 1990;86:706-11.
20. Varrney VA, Hamid QA, Gaga M. Influence of grass pollen immunotherapy on cellular infiltration and cytokine mRNA expression during late phase cutaneous response. Clin Invest 1993;92:644-5.
21. Chen Y, Kuchroo VK, Inobe J, Hafler DA, Weiner HL. Regulatory T cell clones induced by oral tolerance: suppression of autoimmune ekephalomyelitis. Science 1994;265:1237-40.
22. Miller A, Lider O, Roberts AB, Sporn MB. Suppressor T cells generated by oral tolerization to myelin basic protein suppress both in vitro and in vivo immune response by the release of TGFbeta following antigen specific triggering. Proc Natl Acad Sci USA 1992;89:421-5.
23. Holt PG, Sedgwick JD. Suppression of IgE response following antigen inhalation: a natural homeostatic mechanism which limits sensitizations to aeroallergens. Immunol Today 1987;8:14-5.
24. Holt PG, McMenamin C. Defense against allergic sensitization in healthy lung: the role of inhalation tolerance. Clin Exp Allergy 1989;19:55-62.
25. Litwin A, Flanagan M, Entis G, Gottschlich G, Esch R, Gartside P, et al. Immunological effects of an encapsulated short ragweed extract: a potent new agent for oral immunotherapy. Ann Allergy 1996. In press.
26. Einarsson R, Renck B, Taudorf E. In vitro studies of degradation of birch and timothy pollen allergen preparations by human duodenal juice. Allergy 1988;43:469-75.
27. Swarbrick T, Stokes CR, Soothill JF. Absorption of antigens after oral immunisation and the simultaneous induction of specific systemic tolerance. Gut 1979;20:121-5.
28. Mistrello G, Roncarolo D, Gentili M, Zanoni D, Falagiani P. Modified Par j I allergen from P. judaica pollen and its rate of absorption in rats. Immunology Lett 1993;40:31-6.
29. Mistrello G, Rapisarda G, Falagiani P. Detection of IgE-binding activity in serum after intranasal treatment of normal rabbits with P. judaica extracts. Allergy 1991;46:52-5.
30. Fraker PJ, Speck JC. Protein and cell membrane iodination with a sparingly soluble chloramide, 1,3,4,6-tetrachloro-3a, 6a-diphnyl-glycouril. Biochem Biophys Res Commun 1978;80:849-57.
31. Buckle FG, Cohen AB. Nasal mucosal hyperpermeability to macromolecules in atopic rhinitis and extrinsic asthma. J Allergy Clin Immunol 1975;55:213-21.